In the context of cancer, epigenetic changes can lead to the activation of oncogenes or the inactivation of tumor suppressor genes. These alterations can disrupt normal cellular functions, promoting uncontrolled cell growth and proliferation. For example, hypermethylation of tumor suppressor gene promoters can silence their expression, while hypomethylation of oncogene promoters can enhance their activity.
